Péter Kollár

2.0k total citations
63 papers, 1.6k citations indexed

About

Péter Kollár is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Péter Kollár has authored 63 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Organic Chemistry and 9 papers in Pharmacology. Recurrent topics in Péter Kollár's work include Synthesis and biological activity (11 papers), Cancer therapeutics and mechanisms (6 papers) and Fungal Plant Pathogen Control (6 papers). Péter Kollár is often cited by papers focused on Synthesis and biological activity (11 papers), Cancer therapeutics and mechanisms (6 papers) and Fungal Plant Pathogen Control (6 papers). Péter Kollár collaborates with scholars based in Czechia, Slovakia and Ireland. Péter Kollár's co-authors include Ivan Kushkevych, Đani Đorđević, Josef Jampílek, Monika Vítězová, Jiří Kos, Katarína Kráľová, Tomáš Goněc, Aidan Coffey, Matúš Peško and Jakub Treml and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and British Journal of Pharmacology.

In The Last Decade

Péter Kollár

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter Kollár Czechia 27 771 499 191 143 120 63 1.6k
Jitendra Kumar Saxena India 27 593 0.8× 650 1.3× 79 0.4× 181 1.3× 143 1.2× 99 2.0k
Sattu Kamaraj India 25 786 1.0× 155 0.3× 167 0.9× 234 1.6× 98 0.8× 43 1.8k
Hiroshi Aoyama Brazil 26 888 1.2× 503 1.0× 199 1.0× 302 2.1× 64 0.5× 107 2.1k
Mohnad Abdalla China 25 634 0.8× 316 0.6× 135 0.7× 234 1.6× 85 0.7× 145 1.9k
N. S. Hari Narayana Moorthy India 25 855 1.1× 950 1.9× 198 1.0× 114 0.8× 71 0.6× 126 2.4k
Xueqing Li China 24 595 0.8× 268 0.5× 246 1.3× 171 1.2× 106 0.9× 100 2.5k
Xilong Xiao China 30 939 1.2× 473 0.9× 301 1.6× 263 1.8× 310 2.6× 68 2.4k
Carole Di Giorgio France 29 689 0.9× 672 1.3× 124 0.6× 418 2.9× 139 1.2× 80 2.4k
Anees Ahmed Khalil Pakistan 25 693 0.9× 183 0.4× 268 1.4× 513 3.6× 72 0.6× 90 2.5k
K. Sandeep Prabhu United States 37 934 1.2× 194 0.4× 427 2.2× 295 2.1× 147 1.2× 87 3.2k

Countries citing papers authored by Péter Kollár

Since Specialization
Citations

This map shows the geographic impact of Péter Kollár's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Kollár with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Kollár more than expected).

Fields of papers citing papers by Péter Kollár

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Kollár. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Kollár. The network helps show where Péter Kollár may publish in the future.

Co-authorship network of co-authors of Péter Kollár

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Kollár. A scholar is included among the top collaborators of Péter Kollár based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Kollár. Péter Kollár is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goněc, Tomáš, Michal Oravec, Izabela Jendrzejewska, et al.. (2025). Antimicrobial and ADME properties of methoxylated, methylated and nitrated 2-hydroxynaphthalene-1 carboxanilides. ADMET & DMPK. 13(1). 2642–2642. 1 indexed citations
2.
Garaj, Vladimír, et al.. (2025). New potent N‐hydroxycinnamamide‐based histone deacetylase inhibitors suppress proliferation and trigger apoptosis in THP‐1 leukaemia cells. Archiv der Pharmazie. 358(4). e2400889–e2400889. 1 indexed citations
3.
Pérez‐Pérez, María‐Jesús, et al.. (2023). Salicylanilides and Their Anticancer Properties. International Journal of Molecular Sciences. 24(2). 1728–1728. 10 indexed citations
4.
Goněc, Tomáš, Péter Kollár, Michal Oravec, et al.. (2022). Antistaphylococcal Activities and ADME-Related Properties of Chlorinated Arylcarbamoylnaphthalenylcarbamates. Pharmaceuticals. 15(6). 715–715. 3 indexed citations
5.
Kollár, Péter, et al.. (2022). Aminopeptidase N Inhibitors as Pointers for Overcoming Antitumor Treatment Resistance. International Journal of Molecular Sciences. 23(17). 9813–9813. 6 indexed citations
6.
Dall’Acqua, Stefano, et al.. (2021). Antiproliferative and cytotoxic activities of C-Geranylated flavonoids from Paulownia tomentosa Steud. Fruit. Bioorganic Chemistry. 111. 104797–104797. 10 indexed citations
7.
Kushkevych, Ivan, Đani Đorđević, Péter Kollár, Monika Vítězová, & Lorenzo Drago. (2019). Hydrogen Sulfide as a Toxic Product in the Small–Large Intestine Axis and its Role in IBD Development. Journal of Clinical Medicine. 8(7). 1054–1054. 74 indexed citations
8.
Kollár, Péter, et al.. (2019). Prenylated phenols with cytotoxic and antiproliferative activity isolated from Morus alba. Česká a slovenská farmacie. 68(2). 48–68. 1 indexed citations
9.
Kushkevych, Ivan, Đani Đorđević, & Péter Kollár. (2018). Analysis of physiological parameters of Desulfovibrio strains from individuals with colitis. Open Life Sciences. 13(1). 481–488. 52 indexed citations
10.
Kos, Jiří, Iveta Zadražilová, Michal Šoral, et al.. (2015). Ring-substituted 8-hydroxyquinoline-2-carboxanilides as potential antimycobacterial agents. Bioorganic & Medicinal Chemistry. 23(15). 4188–4196. 31 indexed citations
11.
Peško, Matúš, et al.. (2013). Synthesis and Biological Evaluation of 2‐Hydroxy‐3‐[(2‐aryloxyethyl)amino]propyl 4‐[(Alkoxycarbonyl)amino]benzoates. The Scientific World JOURNAL. 2013(1). 274570–274570. 16 indexed citations
12.
Kollár, Péter, et al.. (2013). Marine natural products: Bryostatins in preclinical and clinical studies. Pharmaceutical Biology. 52(2). 237–242. 78 indexed citations
13.
Peško, Matúš, Jiahui Guo, Marcela Vejsová, et al.. (2012). Anti-infective and herbicidal activity of N-substituted 2-aminobenzothiazoles. Bioorganic & Medicinal Chemistry. 20(24). 7059–7068. 46 indexed citations
14.
Pěnčíková, Kateřina, et al.. (2012). Investigation of sanguinarine and chelerythrine effects on LPS-induced inflammatory gene expression in THP-1 cell line. Phytomedicine. 19(10). 890–895. 43 indexed citations
15.
Kollár, Péter, et al.. (2011). Cytotoxicity and effects on inflammatory response of modified types of cellulose in macrophage-like THP-1 cells. International Immunopharmacology. 11(8). 997–1001. 41 indexed citations
16.
Kollár, Péter, et al.. (2010). Geranylated flavanone tomentodiplacone B inhibits proliferation of human monocytic leukaemia (THP‐1) cells. British Journal of Pharmacology. 162(7). 1534–1541. 28 indexed citations
17.
Hošek, Jan, et al.. (2010). Effect of solvent on cytotoxicity and bioavailability of fatty acids. Immunopharmacology and Immunotoxicology. 32(3). 462–465. 6 indexed citations
18.
Stejskal, David, et al.. (2007). Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clinical Biochemistry. 41(4-5). 313–316. 50 indexed citations
19.
Bébarová, Markéta, et al.. (2007). Antiarrhythmic effect of newly synthesized compound 44Bu on model of aconitine-induced arrhythmia — Compared to lidocaine. European Journal of Pharmacology. 575(1-3). 127–133. 19 indexed citations
20.
Kotolová, Hana, Péter Kollár, & Markéta Jarošová. (2006). Carvedilol Protects against Cyclosporine Nephropathy in Rats. Acta Veterinaria Brno. 75(1). 85–89. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026